Zobrazeno 1 - 10
of 1 129
pro vyhledávání: '"Settergren, G."'
Autor:
Maia T; Patient Centered Solutions, IQVIA, 2740-266 Porto Salvo, Portugal., Yokota R; Epidemiology & Pharmacovigilance, P95, 3001 Leuven, Belgium., Arnetorp S; Health Economics & Payer Evidence, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, 431 83 Gothenburg, Sweden., Smith J; Patient representative, Vale of Glamorgan, UK., Rae-Garwood G; Patient representative, Glendale, AZ, USA., Settergren G; Global Evidence Portfolio Delivery, BioPharmaceuticals Medical, AstraZeneca, 431 83 Gothenburg, Sweden., Eckerd M; Global Patient Engagement R&I, AstraZeneca, Wilmington, DE 19850, USA., Williams P; Patient Centered Solutions, IQVIA, 92400 Courbevoie, France.; Patient Centered Science, Vaccine & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, 431 83 Gothenburg, Sweden.
Publikováno v:
International journal of environmental research and public health [Int J Environ Res Public Health] 2024 Sep 30; Vol. 21 (10). Date of Electronic Publication: 2024 Sep 30.
Autor:
Williams P; Global Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.; Patient Centered Solutions, IQVIA, Courbevoie, France., Herring TA; Medical Evidence, Epidemiology, Vaccine & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, United States., Yokota RTC; P95, Epidemiology & Pharmacovigilance, Leuven, Belgium., Maia T; Patient Centered Solutions, IQVIA, Porto Salvo, Portugal., Venkatesan S; BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom., Marcus JC; Patient Centered Solutions, IQVIA, Washington, DC, United States., Settergren G; Global Evidence Portfolio Delivery, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Arnetorp S; Health Economic & Payer Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Lloyd A; Acaster Lloyd Consulting Ltd, London, United Kingdom., Severens JL; Severens HTA Consultancy, Venray, Netherlands., Varni JW; Texas A&M University, College Station, TX, United States., Dixon S; Patient representative, Sulphur Springs, TX, United States., Hamusankwa L; Patient representative, London, United Kingdom., Powell PA; Sheffield Centre for Health and Related Research (SCHARR), University of Sheffield, Sheffield, United Kingdom.; Philip A Powell Consulting, Sheffield, United Kingdom., Taylor S; Medical Evidence, Vaccine & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom., Ware JE Jr; John Ware Research Group, Watertown, ME, United States., Krol M; Patient Centered Solutions, IQVIA, Amsterdam, Netherlands.
Publikováno v:
JMIR research protocols [JMIR Res Protoc] 2024 Aug 13; Vol. 13, pp. e52643. Date of Electronic Publication: 2024 Aug 13.
Publikováno v:
In Value in Health June 2023 26(6) Supplement:S322-S322
Publikováno v:
Acta Anaesthesiologica Scandinavica. Apr2001, Vol. 45 Issue 4, p441-448. 8p.
Autor:
Settergren, G.1 ggsettergren@swipnet.se, Machado, C.2
Publikováno v:
Acta Anaesthesiologica Scandinavica. Mar2011, Vol. 55 Issue 3, p340-343. 4p.
Autor:
Settergren, G.1
Publikováno v:
Acta Anaesthesiologica Scandinavica. Oct2003, Vol. 47 Issue 9, p1053-1058. 6p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Aiwen Feng1,2 fengheyan-2000@163.com, Shaosheng Su1, Cheng Li2, Yutian Kang3, Jiasheng Qiu1,2, Jun Zhou1,2
Publikováno v:
Pharmaceutical Biology. Dec2024, Vol. 62 Issue 1, p53-61. 9p.
Publikováno v:
Acta Anaesthesiologica Scandinavica; Jan2005, Vol. 49 Issue 1, p35-40, 6p
Publikováno v:
Scandinavian Journal of Thoracic & Cardiovascular Surgery; 1981, Vol. 15 Issue 3, p257-262, 6p